Which patients with ischemic stroke and insulin resistance may benefit from pioglitazone hydrochloride?

Graeme J. Hankey

UWA Medical School

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1294-1296
Number of pages	3
Journal	JAMA Neurology
Volume	74
Issue number	11
DOIs	https://doi.org/10.1001/jamaneurol.2017.2142
Publication status	Published - 1 Nov 2017

Access to Document

10.1001/jamaneurol.2017.2142

Other files and links

Link to publication in Scopus

Cite this

@article{d44340ef557a4246933aa158c327feec,

title = "Which patients with ischemic stroke and insulin resistance may benefit from pioglitazone hydrochloride?",

author = "Hankey, {Graeme J.}",

year = "2017",

month = nov,

day = "1",

doi = "10.1001/jamaneurol.2017.2142",

language = "English",

volume = "74",

pages = "1294--1296",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Which patients with ischemic stroke and insulin resistance may benefit from pioglitazone hydrochloride?

AU - Hankey, Graeme J.

PY - 2017/11/1

Y1 - 2017/11/1

UR - http://www.scopus.com/inward/record.url?scp=85034651808&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2017.2142

DO - 10.1001/jamaneurol.2017.2142

M3 - Editorial

C2 - 28975238

AN - SCOPUS:85034651808

SN - 2168-6149

VL - 74

SP - 1294

EP - 1296

JO - JAMA Neurology

JF - JAMA Neurology

IS - 11

ER -